Litigation Details for AMGEN INC v. SANDOZ INC. (D.N.J. 2018)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2018-06-26
Court	District Court, D. New Jersey	Date Terminated	2021-09-28
Cause	15:1126 Patent Infringement	Assigned To	Michael Andre Shipp
Jury Demand	None	Referred To	Douglas Arpert
Parties	HERITAGE PHARMACEUTICALS INC.
Patents	10,092,541; 6,962,940; 7,012,066; 7,208,516; 7,427,638; 7,659,302; 7,893,101; 8,455,536; 8,802,717; 9,000,002; 9,018,243; 9,724,330; 9,872,854
Attorneys	MARK S. OLINSKY
Firms	Eric I. Abraham
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2021-05-05			Infringement Opinions of Dr. Alexis Regarding U.S. Patent No. 10,092,541, 363 MOTION in Limine No. 2: Regarding Defendants…Regarding Exclusion of Dr. Gordon Gribble's European Patent Law Testimony, 351 MOTION in Limine to Preclude… 28 September 2021 3:18-cv-11026 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-06-26	1	Complaint	United States Patent Nos. 6,962,940 (“the ’940 Patent”), 7,208,516 (“the ’516 Patent”), 7,427,638 (“… U.S. Patent Nov. 8, 2005 Sheet 1 of 2 US 6,962,940 B2 …PageID: 71 U.S. Patent Nov. 8, 2005 Sheet 2 of 2 US 6,962,940 B2 … US 6,962,940 B2 Muller et al. (45) Date… US 6,962,940 B2	External link to document
2021-05-04	355	In Limine	Infringement Opinions of Dr. Alexis Regarding U.S. Patent No. 10,092,541 by ALKEM LABORATORIES LTD.. (CAPUZZI, KEVIN… 28 September 2021 3:18-cv-11026 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document